Clinical Trial

Efficacy and Tolerability of the APD Treatment in PAED Patients

Study acronym: SilenciaPAED
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The Silencia PD (peritoneal dialysis) cycler offers a pediatric (PAED) mode with advanced features such as Time and Volume Optimization (TAVO), supporting precise and individualized treatment. This study evaluates the efficacy and tolerability of Automated Peritoneal Dialysis (APD) using the Silencia PD cycler in patients weighing ≤ 20 kg and able to tolerate a minimum inflow volume of 100 mL. The primary objective is to determine whether patients achieve a total weekly Kt/Vurea ≥ 1.8.
Trial Details
NCT Number NCT07004907
Lead Sponsor Fresenius Medical Care Deutschland GmbH
Conditions Renal Failure Acute Chronic
Enrollment 13 participants
Start Date 2026-01
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-06-04